http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017043914-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91b64fe50c5ad2b397e2b1c3b5528904 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-185 |
| filingDate | 2016-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b138fc4fc71b1a8de4ea99203d9a2f48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_088226be74387b28b1435086bf3362d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08a68821288eb6cb6ec8c081dc16e733 |
| publicationDate | 2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017043914-A2 |
| titleOfInvention | Pharmaceutical composition comprising salicornia spp. as an active ingredient for the prevention or treatment of thrombosis, and health functional food comprising the same |
| abstract | The present invention relates to a pharmacuetical composition for preventing or treating thrombosis, comprising an extract of Salicornia europaea ( Salicornia spp.) containing phenolic acids and flavonols as active ingredients. The composition of the present inventoin: exhibits a strong anti-thrombotic activity through an effect of inhibiting platelet aggregation, which initiates the formation of blood clots, together with the inhibition of blood clot formation-related enzymes and blood coagulation factors; never exhibits a hemolytic activity on human erythrocytes; has an excellent thermal stability; and does not exhibit the loss of a blood coagulation factor inhibitory effect and a blood clot formation-related enzyme inhibitory effect even in acidic conditions of pH 2 and in the plasma, and therefore, the composition of the present invention is expected to be used for the prevention and treatment of thrombosis, such as an ischemic stroke and a hemorrhagic stroke, through the improvement of blood circulation. The composition of the present invention is processed in various forms, such as an extract, a powder, a pill, and a tablet, and can be formulated in the form that allows the composition to be taken at any time. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020171726-A1 |
| priorityDate | 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.